SCHEMBL20074019

SCHEMBL20074019

CCc1cc(C(=O)NC)nc2cc(-c3ccc(Br)cc3F)nn12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.35
BRD4 O60885 1/20 0.34
BRD2 P25440 1/20 0.34
BRD3 Q15059 1/20 0.34
BRDT Q58F21 1/20 0.34
TP53 P04637 3/20 0.34
MAPT P10636 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
MAP2K1 Q02750 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18198351 0.89 MCL1 (0.36) TP53MAPTMEN1NPC1RAB9A
SCHEMBL18198400 0.86 MAPT (0.44) TP53MAPTTHRBMEN1NPC1
SCHEMBL18198425 0.85 AAK1 (0.37) TP53MAPTL3MBTL1ALOX5APFEN1
SCHEMBL18198436 0.81 HSD17B10 (0.31) TP53MAPTMEN1KMT2AKDM4E
SCHEMBL18198402 0.79
SCHEMBL20064811 0.78 MCL1 (0.34) TP53MAPTPOLBKDM4E
SCHEMBL18198537 0.78 HPGD (0.46) TP53L3MBTL1MEN1NPC1RAB9A
SCHEMBL18198357 0.78 HPGD (0.46) TP53L3MBTL1MEN1NPC1RAB9A
SCHEMBL20064853 0.78 KMT2A (0.39) TP53MAPTMEN1NPC1RAB9A
SCHEMBL18198423 0.77 GPR119 (0.33) MAPTL3MBTL1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208048-B2 RSV antiviral pyrazolo- and triazolo-pyrimidine compounds JANSSEN SCIENCES IRELAND UC (IE) 2019-02-19 US disclosed
US-20180105529-A1 RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS JANSSEN SCIENCES IRELAND UC (IE) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208048-B2 RSV antiviral pyrazolo- and triazolo-pyrimidine compounds ZC3HAV1, MAVS, TYMP MET 3898/4885BRD4 856/4885BRD2 2508/4885
US-20180105529-A1 RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS ZC3HAV1, MAVS, TYMP MET 3898/4885BRD4 856/4885BRD2 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.